CMS released its proposed rules for Stage 3 meaningful use for the Medicare and Medicaid Electronic Health Records Incentive Programs. The proposed rules will include greater flexibility and drive interoperability, according to HHS.
CMS released its proposed rules for Stage 3 meaningful use for the Medicare and Medicaid Electronic Health Records (EHRs) Incentive Programs. The proposed rules will include greater flexibility and drive interoperability, according to HHS.
“This Stage 3 proposed rule does three things: it helps simplify the meaningful use program, advances the use of health IT toward our vision for improving health delivery, and further aligns the program with other quality and value programs,” Patrick Conway, MD, MSc, CMS acting principal deputy administrator and chief medical officer, said in a statement. “And, in an effort to make reporting easier for health care providers, we will be proposing a new meaningful use reporting deadline soon.”
Dr Conway had hinted that the proposed rules would include greater flexibility when he wrote in a blog post in January that CMS was considering shortening the EHR reporting period to 90 days.
Stage 3 is expected to be the final stage of meaningful use so that in 2018 all providers would report on meaningful use at the Stage 3 level. One of the objectives includes having providers and hospitals provide a summary of care record when transitioning or referring patients to another care setting. In addition, providers and hospitals will need to retrieve a summary of care record during the first encounter with a new patient and incorporate the information from other providers into their own EHR.
“The flow of information is fundamental to achieving a health system that delivers better care, smarter spending, and healthier people,” said HHS Secretary Sylvia M. Burwell. “The steps we are taking today will help to create more transparency on cost and quality information, bring electronic health information to inform care and decision making, and support population health.”
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More